Europe’s drug regulator wins court backing for data transparency policy

BMJ ◽  
2020 ◽  
pp. m302 ◽  
Author(s):  
Clare Dyer
Keyword(s):  
Drug Regulator ◽  
Data Transparency

Promote Good Governance in Public Financial: The Practice of Local Budget (APBD) Transparency Through Open Data Jakarta in Jakarta Provincial Government

2019 ◽  
Vol 15 (1) ◽  
Author(s):  
Dodi Faedlulloh ◽  
Fetty Wiyani
Keyword(s):  
Public Finance ◽  
Good Governance ◽  
Open Data ◽  
Public Trust ◽  
Provincial Government ◽  
Financial Governance ◽  
One Stop ◽  
Data Portal ◽  
Data Transparency ◽  
Local Budget

This paper aimed to explain public financial governance based on good governance implementation in Jakarta Provincial Government. This paper specifically discussed towards transparancy implementation of local budget (APBD) through open data portal that publishes budget data to public. In general, financial transparency through open data has met Transparency 2.0 standards, namely the existence of encompassing, one-stop, one-click budget accountability and accessibility. But there are indeed some shortcomings that are still a concern in order to continue to maintain commitment to the principle of transparency, namely by updating data through consistent data visualization.Transparency of public finance needs to continue to be developed and improved through various innovations to maintain public trust in the government.Keywords: Public Finance, Open Data, Transparency

scholarly journals On Blockchain Integration with Supply Chain: Overview on Data Transparency

Logistics ◽  
2021 ◽  
Vol 5 (3) ◽  
pp. 46
Author(s):  
Houssein Hellani ◽  
Layth Sliman ◽  
Abed Ellatif Samhat ◽  
Ernesto Exposito
Keyword(s):  
Supply Chain ◽  
Data Access ◽  
Sensitive Data ◽  
Promising Technology ◽  
Data Transparency

Data transparency is essential in the modern supply chain to improve trust and boost collaboration among partners. In this context, Blockchain is a promising technology to provide full transparency across the entire supply chain. However, Blockchain was originally designed to provide full transparency and uncontrolled data access. This leads many market actors to avoid Blockchain as they fear for their confidentiality. In this paper, we highlight the requirements and challenges of supply chain transparency. We then investigate a set of supply chain projects that tackle data transparency issues by utilizing Blockchain in their core platform in different manners. Furthermore, we analyze the projects’ techniques and the tools utilized to customize transparency. As a result of the projects’ analyses, we identified that further enhancements are needed to set a balance between the data transparency and process opacity required by different partners, to ensure the confidentiality of their processes and to control access to sensitive data.

Recent developments in China’s biopharmaceutical industry (2012-2017)

2019 ◽  
Vol 10 (3) ◽  
pp. 686-707
Author(s):  
Marcus Conlé
Keyword(s):  
Product Innovation ◽  
Academic Research ◽  
Domestic Market ◽  
Growth Strategy ◽  
Future Research ◽  
Biopharmaceutical Industry ◽  
Content Type ◽  
Drug Regulator ◽  
Recent Developments ◽  
Product Portfolios

Purpose The paper aims to take stock of China’s recent biopharmaceutical industry development by analyzing product innovation and changes in the firms’ product portfolios during the five-year period between 2012 and 2017. Design/methodology/approach The paper introduces a classification of biopharmaceutical products. By applying the classification to the product data of China’s drug regulator, the CFDA, it becomes possible to trace the developments within the sector by looking at changes in the number of firms within each subgroup and changes in the number of subgroups in which each firm is involved. The classification allows an evaluation of the latest product innovation achievements. Findings The paper demonstrates a mild shakeout of firms in the relatively long-existing domestic market segments, a trend toward more specialized product portfolios and an enduring prevalence of innovation strategies aimed at exploiting relatively unpopulated domestic market niches instead of pioneering entirely new products. Especially the capability of upgrading to second-generation protein therapeutics has become a key criterion for separating the wheat and the chaff in China’s domestic sector. The paper moreover points out the relevance of acquisitions as a corporate growth strategy. Research limitations/implications The research does not consider complementary indicators, product pipelines in particular. Future research should compare patterns across emerging economies. Originality/value The paper is unique in using the CFDA database for systematic academic research on (bio)pharmaceutical innovation and in introducing a biopharmaceutical product classification to trace innovative activities and changes in corporate product portfolios over time.

Trial participants call for drug regulator to ensure study results are published

BMJ ◽  
2013 ◽  
Vol 346 (jan18 1) ◽  
pp. f382-f382
Author(s):  
Z. Kmietowicz
Keyword(s):  
Study Results ◽  
Drug Regulator ◽  
Trial Participants

Data Transparency Lab Kick Off Workshop (DTL 2014) Report

2015 ◽  
Vol 45 (2) ◽  
pp. 44-48 ◽  
Author(s):  
Rafael Gross-Brown ◽  
Michal Ficek ◽  
Jose Luis Agundez ◽  
Patrick Dressler ◽  
Nikolaos Laoutaris
Keyword(s):  
Data Transparency

Ethnography, Data Transparency, and the Information Age

2021 ◽  
Vol 47 (1) ◽  
Author(s):  
Alexandra K. Murphy ◽  
Colin Jerolmack ◽  
DeAnna Smith
Keyword(s):  
Social Life ◽  
New Technologies ◽  
Information Age ◽  
Annual Review ◽  
Publication Date ◽  
Ethical Implications ◽  
The Social ◽  
Share Data ◽  
Replication Crisis ◽  
Data Transparency

The conventions ethnographers follow to gather, write about, and store their data are increasingly out of sync with contemporary research expectations and social life. Despite technological advancements that allow ethnographers to observe their subjects digitally and record interactions, few follow subjects online and many still reconstruct quotes from memory. Amid calls for data transparency, ethnographers continue to conceal subjects’ identities and keep fieldnotes private. But things are changing. We review debates, dilemmas, and innovations in ethnography that have arisen over the past two decades in response to new technologies and calls for transparency. We focus on emerging conversations around how ethnographers record, collect, anonymize, verify, and share data. Considering the replication crisis in the social sciences, we ask how ethnographers can enable others to reanalyze their findings. We address ethical implications and offer suggestions for how ethnographers can develop standards for transparency that are consistent with their commitment to their subjects and interpretive scholarship. Expected final online publication date for the Annual Review of Sociology, Volume 47 is July 2021. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

Sign in / Sign up

Export Citation Format

Share Document